Loading insider details...
Beta
Latest Form 4 (Aug 5, 2026): Disposition to Issuer of 240 GRTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | Galera Therapeutics, Inc. (GRTX) | Disposition to Issuer | 240 | n/a |
| Feb 26, 2025 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 48,000 | n/a |
| Jun 16, 2023 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 48,000 | n/a |
| Jun 16, 2022 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 15,000 | n/a |
| Jun 17, 2021 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 9,888 | n/a |
| Jun 10, 2020 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 9,888 | n/a |